Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection Article

Lee, Jared, Lee, Ji-Young, Meade, Christina S et al. (2020). Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection . JOURNAL OF NEUROVIROLOGY, 26(5), 779-784. 10.1007/s13365-020-00841-4

Open Access International Collaboration

cited authors

  • Lee, Jared; Lee, Ji-Young; Meade, Christina S; Cohn, Michael; Chahine, Antonio; Dilworth, Samantha E; Magidson, Jessica F; Gouse, Hetta; Fuchs, Dietmar; Carrico, Adam W

sustainable development goals

authors

publication date

  • October 1, 2020

published in

keywords

  • DYSFUNCTION
  • HIV
  • IMMUNE ACTIVATION
  • IMPAIRMENT
  • IMPULSIVITY
  • Impulsivity
  • Life Sciences & Biomedicine
  • MORTALITY
  • Methamphetamine
  • Neurosciences
  • Neurosciences & Neurology
  • PREFRONTAL CORTEX
  • Risk-taking propensity
  • SEXUAL RISK
  • STIMULANT USE
  • SUBSTANCE-USE
  • Science & Technology
  • Tryptophan
  • VULNERABILITY
  • Virology

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 779

end page

  • 784

volume

  • 26

issue

  • 5